Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Inozyme Pharma
700 Technology Square
Cambridge, MA 02139
Phone: 203-442-3597
https://www.inozyme.com/

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcification of soft tissues and under mineralization of bone. The company was founded in 2016 with technology licensed from Yale University.

Key Contact
Name
Axel Bolte
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/15/17 $49,000,000 Series A Longitude Capital
Novo Ventures
Sanofi Ventures
undisclosed
04/10/19 $67,000,000 Series A-2 Cowen Healthcare Investments
Longitude Capital
New Enterprise Associates
Novo Holdings
RA Capital Management
Rock Springs Capital
Sanofi Ventures
Sofinnova Ventures
undisclosed